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INTRODUCTION
Toxoplasmosis is a common disease that occurs worldwide in birds and
warm-blooded mammals including humans(1). It is caused by infection of a
single-celled parasite called Toxoplasma gondii(1).
Toxoplasma gondii infection is a frequent cause of uveitis(1-5). Toxo-
plasma gondii is an obligate intracellular parasite and infection is wides-
pread in nature.
Human toxoplasmosis may occur in either a congenital or an ac-
quired form. Serologic evidence of previous Toxoplasma gondii infec-
tion is present in 20% to 70% of the population of the United States of
America(6-7).
Toxoplasma gondii is a coccidian classified as belonging to the phylum
Apicomplexa, class Sporozoa, order Eucoccidia and suborder Eimeria. The
infection is a zoonosis and members of the cat family are the definitive hosts(8-17).
Acute systemic toxoplasmosis in normal hosts is most often a subcli-
nical infection but may present as a mild flu-like illness. The disease is
controlled by the host’s immune response to the acute infection. If the
parasite reaches the eye, a focus of infection is established, which progres-
ses from mainly a retinitis with some spillover inflammation into the
adjacent choroid and vitreous(1).
It is estimated that about two-thirds of patients with toxoplasmosis have
recurrent episodes of inflammation(18). Various mechanisms have been
hypothesized as the cause of recurrent inflammatory episodes including: (1)
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Purpose: To report the findings of indocyanine green angiography
performed in patients with recurrent ocular toxoplasmosis. Methods:
Institutional prospective analysis of 23 eyes from 23 immunocompetent
patients with recurrent ocular toxoplasmosis aged between 17 and 41
years. These patients underwent a complete ocular examination including
indocyanine green angiography. Results: Multiple hypofluorescent
spots distant from the recurrent active lesion of retinochoroidal toxo-
plasmosis were found in 26.08% of the patients. We also found multiple
hypofluorescent satellite dots in 69.56% of the patients. Conclusion:
These remote dots seen suggest either a more widespread choroidal
involvement in this disease and this can represent simply remote collections
of inflammatory cells or subclinical infection.
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reactivation of Toxoplasma gondii cysts within the retina; (2) an
autoimmune response to remaining retinal antigen; and (3) rein-
fection with live organisms. The first two mechanisms are sup-
ported by the observation that recurrent lesions frequently de-
velop at the borders of old retinochoroidal scars(18).
Indocyanine green angiography (ICG) has been used to study
inflammatory chorioretinal diseases(19-20) and toxoplasmosis(21-23).
In toxoplamosis, recurrent active retinal lesions on fluo-
rescein angiography present hypofluorescence in the center
and staining of the dye on the edge of the lesions of acute
recurrent active retinitis(2).
On indocyanine green angiography, recurrent active reti-
nal lesions are hypofluorescent in all phases of the study.
Satellite dark dots have been described around the hypofluo-
rescent recurrent active lesion(21).
We analyzed a case series of patients with recurrent ocular
toxoplasmosis using ICG angiographic studies and sought to
present the respective findings in this study.
METHODS
This is an Institutional prospective study. The study
protocol was approved by the Medical Research Ethics Com-
mitee of Universidade Federal de São Paulo (Escola Paulista
de Medicina). We evaluated 23 eyes of 23 immunocompetent
patients, between January 2001 and June 2004. There were 10
females and 13 males with age ranging from 17 to 41 years,
with a mean age of 29. All patients had unilateral recurrent
toxoplasmic retinitis, at the time of diagnosis.
Presentation of recurrent retinitis was classified in the mo-
ment the patients were diagnosed(23). According to this classi-
fication, the presentation of recurrent retinitis can be one of the
following: (1) large destructive lesions (in which active retinitis
involves an area usually larger than the optic nerve head); (2)
punctate inner retinal lesions (gray area of active retinitis with
minimal edema and vitreous reaction) and; (3) punctuate outer
retinal lesions. The patients underwent an ocular examination
including fluorescein angiography and indocyanine green an-
giography, focusing on the  recurrent active retinal lesion, the
surrounding area and other areas in the ocular fundus. These tests
were performed at the time of diagnosis; with the improvement of
inflammation and; after healing of the recurrent active lesion. All
patients were treated for six weeks with oral antitoxoplasmic
drugs, such as sulfadiazine and pyrimethamine, and folinic acid.
Oral prednisone 20 mg/day was also administered in half of the
patients if they presented vitreous inflammation, or if the
recurrent lesion was located in the posterior pole of the eye, close
to the macular region.
RESULTS
Fluorescein angiography showed hypofluorescence in the
center and staining of the dye on the edge of the retinal
recurrent active lesion in all patients.
ICG angiography showed multiple hypofluorescent dots
surrounding the active lesions in 70% of the eyes (Figure 1).
In 26% of the eyes (six patients) hypofluorescent dots (Figu-
res 2 and 3) were also seen in areas of the fundus distant from
the active recurrent lesion and in areas of retina that appea-
red normal on fundoscopy and fluorescein angiography at
the moment of the diagnosis.
They are noticed in all the three morphologic variations
of retinitis presentation. The remote dots were found in six
patients and three of them were treated with antitoxoplasmic
drugs plus steroid and the other three patients were treated
with antitoxoplasmic drugs alone. Both the adjacent and
remote hypofluorescent spots disappeared after treatment
and control of the active inflammation.
DISCUSSION
Researchers agree that patients have a life-long risk of
recurrences. A steady rise in the cumulative prevalence of
patients who have had disease recurrences(24) was demons-
trated. However, other authors(23) found that the frequency of
recurrence drops in many patients after a few years, and that
they eventually cease to occur. This decline in the frequency
of recurrences could be related to host factors, either invol-
ving sequestration of tissue cysts or improved immunologi-
cal control of infection. The latter possibility is unlikely,
however, in view of the fact that immune defenses are belie-
ved to decline with age. As a result, ocular diseases may
actually be more severe in older patients. Another possibi-
lity is that tissue cysts have a finite lifespan in human hosts,
and that patients will eventually have no tissue cysts that
could reactivate. It is unlikely that this pattern of recurren-
ces is the result of therapy, since there has been no demons-
trable effect of short-term treatment on the intervals to first
recurrences.
A study(23) suggested that recurrences can develop in
clusters, and that there can be long intervals between clus-
ters. A theory(18) for this is that the clustering effect might be
explained by the fact that, with a given recurrence, the local
number of tissue cysts increases through proliferation of
organisms during the active phase of disease, thereby increa-
sing the likelihood that at least one tissue cyst will subse-
quently reactivate. The risk of recurrences would again drop
over time, as tissue cysts became nonviable; eventually,
some disorder of host defenses would allow another episode
if any viable tissue remained in the retina, then the number
of tissue cysts would increase again, thereby initiating ano-
ther cycle of frequent recurrences.
In conclusion, our study shows intriguing findings when
observing the results of ICG angiography in a case series of
recurrent ocular toxoplasmosis, despite the fact that multiple
hypofluorescent dots have been previously seen in inflam-
matory chorioretinal diseases(19-20). In ocular toxoplasmosis
the most common finding is the occurrence of hypofluores-
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cent dots surrounding the active lesions called satellite dark
dots, which were seen in approximately 75% of the cases in a
small case series(21-25). It was hypothesized that these hypofluo-
rescent dots represent additional areas of infection because
they progressed to white lesion in two cases(26). We also found
hypofluorescent dots around the active lesions. In addition,
Figure 1- A) Nasal recurrent active toxoplasmosis; B) Satellite dark dots
A B
A B C
Figure 2 - A) Nasal recurrent active toxoplasmosis; B) Satellite dark dots; C) Remote dots temporal to the macula (marked by the arrowhead)
Figure 3 - A) Juxtamacular recurrent active toxoplasmosis; B) Remote dots in the nasal region (marked by the arrowhead)
A B
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however, there were hypofluorescent dots distant from active
recurrent lesions in areas that appeared normal on fundoscopy
and fluorescein angiography. These remote dots were seen in
26% of the eyes in our case series.
CONCLUSION
The presence of these remote dots suggests either a more
widespread infectious disease than suspected or perhaps just
sterile choroidal inflammation as a general response to intra-
ocular inflammation. We believe that ICG angiography al-
lowed us to observe results in cases of recurrent ocular to-
xoplasmosis that had not been previously observed. Howe-
ver, further studies will be necessary to elucidate the signifi-
cance of these hypofluorescent remote dots.
RESUMO
Objetivos: Relatar os achados da angiografia com indocia-
nina verde, realizados em pacientes com recidiva de toxo-
plasmose ocular. Métodos: Análise institucional e prospec-
tiva de 23 olhos de 23 pacientes, imunocompetentes com
idades entre 17 e 41 anos. Estes pacientes foram submetidos a
exame oftalmológico de rotina e a angiografia com indocia-
nina verde. Resultados: Foram encontrados múltiplos pontos
hipofluorescentes distantes da lesão ativa recidivada da to-
xoplasmose retino-coroidiana em 26,08% dos casos, chama-
dos por nós de pontos remotos e encontramos também, pon-
tos hipofluorescentes circundando ou próximos da lesão ati-
va recidivada em 69,56% dos casos. Conclusão: Os pontos
hipofluorescentes distantes da lesão ativa recidivada, chama-
dos de pontos remotos, não descritos previamente na doença,
demonstram um maior envolvimento da coróide e podem
significar coleções remotas de células inflamatórias ou infec-
ção subclínica.
Descritores:Toxoplasmose ocular/diagnóstico; Coroidite;
Angiofluoresceinografia; Verde de indocianina/uso diagnós-
tico; Retinite; Recidiva
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